Perflenapent: Difference between revisions
Created page with "{{chembox | ImageFile = Perflenapent.png | ImageSize = 180 | ImageAlt = Structural formula of perflenapent | ImageFile1 = Perfluoropentane 3D ball.png | ImageSize1 = 180 | Ima..." |
m Protected "Perflenapent": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 47: | Line 47: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Perflenapent''' ([[International Nonproprietary Name|INN]]/[[United States Adopted Name|USAN]]), or '''perfluoropentane''' ('''PFP'''), is a [[fluorocarbon]]. It has several biomedical applications including: propellant for pressurized metered dose inhalers;<ref>Rogueda, P. G. A. HPFP, a Model Propellant for pMDIs. Drug Dev. Ind. Phar. 2003, 29, 39</ref> gas core in [[microbubbles|microbubble]] [[Contrast-enhanced ultrasound#Microbubble contrast agents|ultrasound contrast agents]];<ref>Liu, Y., Miyoshi, H., and Nakamura, M. Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene delivery. J. Controlled Release 2006, 114, 89− 99</ref> and [[occlusion therapy]] via the conversion of nanometer liquid [[droplet]]s into micrometer sized gas microbubbles ([[acoustic droplet vaporization]]).<ref>D. Bardin, T. D. Martz, P. S. Sheeran, R. Shih, P. A. Dayton, and A. P. Lee, “High-speed, clinical-scale microfluidic generation of stable phase-change droplets for gas embolotherapy,” Lab on a Chip, vol. 11, no. 23, p. 3990, 2011. | '''Perflenapent''' ([[International Nonproprietary Name|INN]]/[[United States Adopted Name|USAN]]), or '''perfluoropentane''' ('''PFP'''), is a [[fluorocarbon]]. It has several biomedical applications including: propellant for pressurized metered dose inhalers;<ref>Rogueda, P. G. A. HPFP, a Model Propellant for pMDIs. Drug Dev. Ind. Phar. 2003, 29, 39</ref> gas core in [[microbubbles|microbubble]] [[Contrast-enhanced ultrasound#Microbubble contrast agents|ultrasound contrast agents]];<ref>Liu, Y., Miyoshi, H., and Nakamura, M. Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene delivery. J. Controlled Release 2006, 114, 89− 99</ref> and [[occlusion therapy]] via the conversion of nanometer liquid [[droplet]]s into micrometer sized gas microbubbles ([[acoustic droplet vaporization]]).<ref>D. Bardin, T. D. Martz, P. S. Sheeran, R. Shih, P. A. Dayton, and A. P. Lee, “High-speed, clinical-scale microfluidic generation of stable phase-change droplets for gas embolotherapy,” Lab on a Chip, vol. 11, no. 23, p. 3990, 2011. | ||
| Line 61: | Line 58: | ||
{{Contrast media}} | {{Contrast media}} | ||
[[Category:Organofluorides]] | [[Category:Organofluorides]] | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Latest revision as of 16:55, 20 August 2015
| |
| |
| Names | |
|---|---|
| IUPAC name
Dodecafluoropentane
| |
| Other names
Perfluoropentane
| |
| Identifiers | |
| ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
PubChem CID
|
|
| Properties | |
| C5F12 | |
| Molar mass | 288.04 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
|
WikiDoc Resources for Perflenapent |
|
Articles |
|---|
|
Most recent articles on Perflenapent Most cited articles on Perflenapent |
|
Media |
|
Powerpoint slides on Perflenapent |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Perflenapent at Clinical Trials.gov Clinical Trials on Perflenapent at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Perflenapent
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Perflenapent Discussion groups on Perflenapent Patient Handouts on Perflenapent Directions to Hospitals Treating Perflenapent Risk calculators and risk factors for Perflenapent
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Perflenapent |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Perflenapent (INN/USAN), or perfluoropentane (PFP), is a fluorocarbon. It has several biomedical applications including: propellant for pressurized metered dose inhalers;[2] gas core in microbubble ultrasound contrast agents;[3] and occlusion therapy via the conversion of nanometer liquid droplets into micrometer sized gas microbubbles (acoustic droplet vaporization).[4]
References
- ↑ "Perfluoropentane". Retrieved January 14, 2013.
- ↑ Rogueda, P. G. A. HPFP, a Model Propellant for pMDIs. Drug Dev. Ind. Phar. 2003, 29, 39
- ↑ Liu, Y., Miyoshi, H., and Nakamura, M. Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene delivery. J. Controlled Release 2006, 114, 89− 99
- ↑ D. Bardin, T. D. Martz, P. S. Sheeran, R. Shih, P. A. Dayton, and A. P. Lee, “High-speed, clinical-scale microfluidic generation of stable phase-change droplets for gas embolotherapy,” Lab on a Chip, vol. 11, no. 23, p. 3990, 2011.
- Pages using duplicate arguments in template calls
- Pages with script errors
- Articles without InChI source
- Chemical pages without ChemSpiderID
- Articles without EBI source
- Articles without KEGG source
- Articles without UNII source
- Chemical articles with unknown parameter in Chembox
- ECHA InfoCard ID from Wikidata
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Organofluorides
- Drug